Search Results 91-100 of 14178 for anti-TNF drugs

  1. Vaccine efficacy and antibody response among patients with IBD and recipients of immunosuppressive agents - Mayo Clinic

    Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD. MAC-20531112. Medical Professionals; Vaccine efficacy and ...

  2. Arthritis - Diagnosis and treatment - Mayo Clinic

    Medications · NSAIDs . Nonsteroidal anti-inflammatory drugs (NSAIDs) can relieve pain and reduce inflammation. · Counterirritants. Some varieties of creams and ...

  3. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

  4. Monoclonal antibody drugs for cancer: How they work - Mayo Clinic

    If your health care provider recommends a monoclonal antibody drug as part of your cancer treatment, find out what to expect from this therapy. Learn enough ...

  5. Chronic pain: Medication decisions - Mayo Clinic

    Nonsteroidal anti-inflammatory drugs, known as NSAIDs · Acetaminophen · COX-2 inhibitors · Antidepressants and anti-seizure medications · Opioids · Pain medications ...

  6. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

  7. Arthritis pain: Treatments absorbed through your skin - Mayo Clinic

    Topical nonsteroidal anti-inflammatory drugs. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a common treatment for osteoarthritis. But the kind you take ...

  8. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

  9. Publications - Laura E. Raffals, M.D. - Mayo Clinic

    Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients. J Pediatr Surg. 2019 Oct; 54 (10):2162-2165 Epub 2019 Jan ...

  10. Cytotoxic Action of Novel Anti-Neoplastic Agents - Anticancer Drug Action Laboratory - Mayo Clinic Research

    Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the cytotoxic action of novel anti-neoplastic agents.